You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR LUMATEPERONE TOSYLATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for lumateperone tosylate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03817528 ↗	ITI-007 (Lumateperone Tosylate) for Schizophrenia	Terminated	Intra-Cellular Therapies, Inc.	Phase 2	2019-03-01	The purpose of this study is to offer open label ITI-007 treatment to patients who poorly respond or poorly tolerate approved medications.
NCT03817528 ↗	ITI-007 (Lumateperone Tosylate) for Schizophrenia	Terminated	New York State Psychiatric Institute	Phase 2	2019-03-01	The purpose of this study is to offer open label ITI-007 treatment to patients who poorly respond or poorly tolerate approved medications.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for lumateperone tosylate

Condition Name

Chart
Table

Condition Name for lumateperone tosylate
Intervention	Trials
Schizophrenia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for lumateperone tosylate
Intervention	Trials
Schizophrenia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for lumateperone tosylate

Trials by Country

Map
Table

Trials by Country for lumateperone tosylate
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for lumateperone tosylate
Location	Trials
New York	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for lumateperone tosylate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for lumateperone tosylate
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for lumateperone tosylate
Clinical Trial Phase	Trials
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for lumateperone tosylate

Sponsor Name

Chart
Table

Sponsor Name for lumateperone tosylate
Sponsor	Trials
Intra-Cellular Therapies, Inc.	1
New York State Psychiatric Institute	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for lumateperone tosylate
Sponsor	Trials
Industry	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.